nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—TPMT—prostate gland—urinary bladder cancer	0.0274	0.066	CbGeAlD
Bendroflumethiazide—KCNMA1—prostate gland—urinary bladder cancer	0.0255	0.0614	CbGeAlD
Bendroflumethiazide—SLC12A3—renal system—urinary bladder cancer	0.0252	0.0605	CbGeAlD
Bendroflumethiazide—TPMT—seminal vesicle—urinary bladder cancer	0.0232	0.0558	CbGeAlD
Bendroflumethiazide—SLC12A3—female reproductive system—urinary bladder cancer	0.0201	0.0485	CbGeAlD
Bendroflumethiazide—KCNMA1—epithelium—urinary bladder cancer	0.0188	0.0451	CbGeAlD
Bendroflumethiazide—TPMT—renal system—urinary bladder cancer	0.0187	0.045	CbGeAlD
Bendroflumethiazide—TPMT—urethra—urinary bladder cancer	0.0184	0.0442	CbGeAlD
Bendroflumethiazide—KCNMA1—smooth muscle tissue—urinary bladder cancer	0.0181	0.0435	CbGeAlD
Bendroflumethiazide—KCNMA1—renal system—urinary bladder cancer	0.0174	0.0419	CbGeAlD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTZ1—urinary bladder cancer	0.0174	0.0496	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—NAT1—urinary bladder cancer	0.0165	0.047	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTO2—urinary bladder cancer	0.0165	0.047	CbGpPWpGaD
Bendroflumethiazide—CA4—prostate gland—urinary bladder cancer	0.0152	0.0365	CbGeAlD
Bendroflumethiazide—TPMT—Phase II conjugation—UGT2B7—urinary bladder cancer	0.0151	0.043	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—female reproductive system—urinary bladder cancer	0.0139	0.0335	CbGeAlD
Bendroflumethiazide—TPMT—vagina—urinary bladder cancer	0.0135	0.0326	CbGeAlD
Bendroflumethiazide—CA1—renal system—urinary bladder cancer	0.0132	0.0318	CbGeAlD
Bendroflumethiazide—CA4—seminal vesicle—urinary bladder cancer	0.0128	0.0308	CbGeAlD
Bendroflumethiazide—CA2—prostate gland—urinary bladder cancer	0.0126	0.0302	CbGeAlD
Bendroflumethiazide—CA1—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.0114	0.0324	CbGpPWpGaD
Bendroflumethiazide—CA2—seminal vesicle—urinary bladder cancer	0.0106	0.0256	CbGeAlD
Bendroflumethiazide—CA1—female reproductive system—urinary bladder cancer	0.0106	0.0255	CbGeAlD
Bendroflumethiazide—CA4—renal system—urinary bladder cancer	0.0103	0.0248	CbGeAlD
Bendroflumethiazide—TPMT—Biological oxidations—GSTZ1—urinary bladder cancer	0.0102	0.029	CbGpPWpGaD
Bendroflumethiazide—CA4—urethra—urinary bladder cancer	0.0101	0.0244	CbGeAlD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.01	0.0286	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—GSTO2—urinary bladder cancer	0.00963	0.0275	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—NAT1—urinary bladder cancer	0.00963	0.0275	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.0095	0.0271	CbGpPWpGaD
Bendroflumethiazide—CA2—epithelium—urinary bladder cancer	0.00923	0.0222	CbGeAlD
Bendroflumethiazide—TPMT—Phase II conjugation—NAT2—urinary bladder cancer	0.00902	0.0257	CbGpPWpGaD
Bendroflumethiazide—CA2—smooth muscle tissue—urinary bladder cancer	0.0089	0.0214	CbGeAlD
Bendroflumethiazide—TPMT—Biological oxidations—UGT2B7—urinary bladder cancer	0.00881	0.0251	CbGpPWpGaD
Bendroflumethiazide—TPMT—lymph node—urinary bladder cancer	0.00876	0.0211	CbGeAlD
Bendroflumethiazide—TPMT—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00869	0.0248	CbGpPWpGaD
Bendroflumethiazide—CA2—renal system—urinary bladder cancer	0.00857	0.0206	CbGeAlD
Bendroflumethiazide—CA4—female reproductive system—urinary bladder cancer	0.00827	0.0199	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—urinary bladder cancer	0.00815	0.0196	CbGeAlD
Bendroflumethiazide—Allergic cutaneous angiitis—Methotrexate—urinary bladder cancer	0.00799	0.0342	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—CYP4B1—urinary bladder cancer	0.00793	0.0226	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00782	0.0223	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—HPGDS—urinary bladder cancer	0.00721	0.0206	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTT1—urinary bladder cancer	0.007	0.02	CbGpPWpGaD
Bendroflumethiazide—CA2—female reproductive system—urinary bladder cancer	0.00686	0.0165	CbGeAlD
Bendroflumethiazide—CA2—vagina—urinary bladder cancer	0.0062	0.0149	CbGeAlD
Bendroflumethiazide—CA1—lymph node—urinary bladder cancer	0.00619	0.0149	CbGeAlD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.0058	0.0166	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.00574	0.0164	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.00574	0.0164	CbGpPWpGaD
Bendroflumethiazide—Drug interaction—Gemcitabine—urinary bladder cancer	0.00536	0.0229	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—NAT2—urinary bladder cancer	0.00528	0.0151	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00521	0.0149	CbGpPWpGaD
Bendroflumethiazide—Leukocytoclastic vasculitis—Methotrexate—urinary bladder cancer	0.00518	0.0222	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—MPO—urinary bladder cancer	0.00491	0.014	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTP1—urinary bladder cancer	0.00485	0.0138	CbGpPWpGaD
Bendroflumethiazide—CA4—lymph node—urinary bladder cancer	0.00484	0.0116	CbGeAlD
Bendroflumethiazide—TPMT—Phase II conjugation—GSTM1—urinary bladder cancer	0.00446	0.0127	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Valrubicin—urinary bladder cancer	0.00436	0.0187	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—HPGDS—urinary bladder cancer	0.00422	0.012	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Valrubicin—urinary bladder cancer	0.00416	0.0178	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0041	0.0175	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—GSTT1—urinary bladder cancer	0.00409	0.0117	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Valrubicin—urinary bladder cancer	0.00402	0.0172	CcSEcCtD
Bendroflumethiazide—CA2—lymph node—urinary bladder cancer	0.00401	0.00965	CbGeAlD
Bendroflumethiazide—Anorexia—Mitomycin—urinary bladder cancer	0.00399	0.0171	CcSEcCtD
Bendroflumethiazide—Vomiting—Valrubicin—urinary bladder cancer	0.00387	0.0165	CcSEcCtD
Bendroflumethiazide—Rash—Valrubicin—urinary bladder cancer	0.00383	0.0164	CcSEcCtD
Bendroflumethiazide—Dermatitis—Valrubicin—urinary bladder cancer	0.00383	0.0164	CcSEcCtD
Bendroflumethiazide—Polyuria—Cisplatin—urinary bladder cancer	0.00383	0.0164	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Mitomycin—urinary bladder cancer	0.00364	0.0156	CcSEcCtD
Bendroflumethiazide—Nausea—Valrubicin—urinary bladder cancer	0.00361	0.0154	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.00328	0.014	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.00307	0.00877	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.00307	0.00877	CbGpPWpGaD
Bendroflumethiazide—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00307	0.0131	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00306	0.0131	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Cisplatin—urinary bladder cancer	0.00303	0.0129	CcSEcCtD
Bendroflumethiazide—Asthenia—Mitomycin—urinary bladder cancer	0.00301	0.0129	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00295	0.00841	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Mitomycin—urinary bladder cancer	0.00287	0.0123	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Cisplatin—urinary bladder cancer	0.00285	0.0122	CcSEcCtD
Bendroflumethiazide—Blood disorder—Epirubicin—urinary bladder cancer	0.00285	0.0122	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—GSTP1—urinary bladder cancer	0.00284	0.0081	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.0028	0.00798	CbGpPWpGaD
Bendroflumethiazide—Cramp muscle—Etoposide—urinary bladder cancer	0.00277	0.0119	CcSEcCtD
Bendroflumethiazide—Dizziness—Mitomycin—urinary bladder cancer	0.00277	0.0118	CcSEcCtD
Bendroflumethiazide—Vomiting—Mitomycin—urinary bladder cancer	0.00266	0.0114	CcSEcCtD
Bendroflumethiazide—Rash—Mitomycin—urinary bladder cancer	0.00264	0.0113	CcSEcCtD
Bendroflumethiazide—Dermatitis—Mitomycin—urinary bladder cancer	0.00264	0.0113	CcSEcCtD
Bendroflumethiazide—Blood disorder—Doxorubicin—urinary bladder cancer	0.00263	0.0113	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—GSTM1—urinary bladder cancer	0.00261	0.00744	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00257	0.00734	CbGpPWpGaD
Bendroflumethiazide—Nausea—Mitomycin—urinary bladder cancer	0.00249	0.0106	CcSEcCtD
Bendroflumethiazide—Urine output increased—Methotrexate—urinary bladder cancer	0.0023	0.00982	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00213	0.00608	CbGpPWpGaD
Bendroflumethiazide—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.00212	0.00907	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.00212	0.00604	CbGpPWpGaD
Bendroflumethiazide—Polyuria—Methotrexate—urinary bladder cancer	0.0021	0.00898	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00206	0.00882	CcSEcCtD
Bendroflumethiazide—Anorexia—Thiotepa—urinary bladder cancer	0.00201	0.00859	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.00198	0.00848	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Cisplatin—urinary bladder cancer	0.00195	0.00832	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Epirubicin—urinary bladder cancer	0.00193	0.00825	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.00185	0.00529	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TYMS—urinary bladder cancer	0.00185	0.00528	CbGpPWpGaD
Bendroflumethiazide—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.00184	0.00785	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Thiotepa—urinary bladder cancer	0.00183	0.00783	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.00183	0.00522	CbGpPWpGaD
Bendroflumethiazide—Constipation—Thiotepa—urinary bladder cancer	0.0018	0.0077	CcSEcCtD
Bendroflumethiazide—Purpura—Epirubicin—urinary bladder cancer	0.00179	0.00766	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00179	0.00763	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Etoposide—urinary bladder cancer	0.00178	0.00762	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—GSTZ1—urinary bladder cancer	0.00174	0.00496	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00174	0.00496	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00174	0.00742	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—PTGS2—urinary bladder cancer	0.00173	0.00495	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00171	0.00729	CcSEcCtD
Bendroflumethiazide—Anorexia—Gemcitabine—urinary bladder cancer	0.00169	0.00722	CcSEcCtD
Bendroflumethiazide—Anorexia—Fluorouracil—urinary bladder cancer	0.00166	0.0071	CcSEcCtD
Bendroflumethiazide—Purpura—Doxorubicin—urinary bladder cancer	0.00166	0.00708	CcSEcCtD
Bendroflumethiazide—Hypotension—Gemcitabine—urinary bladder cancer	0.00166	0.00708	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—GSTO2—urinary bladder cancer	0.00165	0.0047	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NAT1—urinary bladder cancer	0.00165	0.0047	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—FAS—urinary bladder cancer	0.00164	0.00468	CbGpPWpGaD
Bendroflumethiazide—Hypotension—Fluorouracil—urinary bladder cancer	0.00163	0.00696	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00162	0.00692	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00158	0.00674	CcSEcCtD
Bendroflumethiazide—Anorexia—Cisplatin—urinary bladder cancer	0.00157	0.00673	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00157	0.00672	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.00157	0.00447	CbGpPWpGaD
Bendroflumethiazide—Pancreatitis—Methotrexate—urinary bladder cancer	0.00156	0.00668	CcSEcCtD
Bendroflumethiazide—Hypotension—Cisplatin—urinary bladder cancer	0.00154	0.0066	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00154	0.00659	CcSEcCtD
Bendroflumethiazide—Constipation—Gemcitabine—urinary bladder cancer	0.00152	0.00648	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00151	0.00648	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.00151	0.00432	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Thiotepa—urinary bladder cancer	0.00151	0.00646	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—UGT2B7—urinary bladder cancer	0.00151	0.0043	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00148	0.00634	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00147	0.00628	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Epirubicin—urinary bladder cancer	0.00146	0.00625	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00146	0.00624	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00145	0.00621	CcSEcCtD
Bendroflumethiazide—Anorexia—Etoposide—urinary bladder cancer	0.00144	0.00617	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—CDK4—urinary bladder cancer	0.00144	0.00412	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00144	0.00616	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—EP300—urinary bladder cancer	0.00144	0.00411	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00144	0.00614	CcSEcCtD
Bendroflumethiazide—Hypotension—Etoposide—urinary bladder cancer	0.00141	0.00605	CcSEcCtD
Bendroflumethiazide—Dizziness—Thiotepa—urinary bladder cancer	0.00139	0.00596	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—CYP4B1—urinary bladder cancer	0.00136	0.00387	CbGpPWpGaD
Bendroflumethiazide—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00135	0.00579	CcSEcCtD
Bendroflumethiazide—Vomiting—Thiotepa—urinary bladder cancer	0.00134	0.00573	CcSEcCtD
Bendroflumethiazide—Rash—Thiotepa—urinary bladder cancer	0.00133	0.00568	CcSEcCtD
Bendroflumethiazide—Dermatitis—Thiotepa—urinary bladder cancer	0.00133	0.00567	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Etoposide—urinary bladder cancer	0.00132	0.00562	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PPARG—urinary bladder cancer	0.00131	0.00374	CbGpPWpGaD
Bendroflumethiazide—Constipation—Etoposide—urinary bladder cancer	0.00129	0.00553	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—SLC19A1—urinary bladder cancer	0.00128	0.00366	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Gemcitabine—urinary bladder cancer	0.00127	0.00544	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—GSTZ1—urinary bladder cancer	0.00126	0.00359	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—MYC—urinary bladder cancer	0.00126	0.00358	CbGpPWpGaD
Bendroflumethiazide—Nausea—Thiotepa—urinary bladder cancer	0.00125	0.00535	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—PRSS3—urinary bladder cancer	0.00125	0.00356	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00121	0.00518	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GSTZ1—urinary bladder cancer	0.0012	0.00344	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00119	0.0051	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—GSTO2—urinary bladder cancer	0.00119	0.0034	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NAT1—urinary bladder cancer	0.00119	0.0034	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Cisplatin—urinary bladder cancer	0.00119	0.00507	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00117	0.00335	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.00116	0.00331	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTZ1—urinary bladder cancer	0.00115	0.0033	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Fluorouracil—urinary bladder cancer	0.00115	0.00493	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GSTO2—urinary bladder cancer	0.00114	0.00326	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NAT1—urinary bladder cancer	0.00114	0.00326	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Cisplatin—urinary bladder cancer	0.00113	0.00483	CcSEcCtD
Bendroflumethiazide—Vomiting—Gemcitabine—urinary bladder cancer	0.00113	0.00482	CcSEcCtD
Bendroflumethiazide—Rash—Gemcitabine—urinary bladder cancer	0.00112	0.00478	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00112	0.00477	CcSEcCtD
Bendroflumethiazide—Vomiting—Fluorouracil—urinary bladder cancer	0.00111	0.00474	CcSEcCtD
Bendroflumethiazide—Rash—Fluorouracil—urinary bladder cancer	0.0011	0.0047	CcSEcCtD
Bendroflumethiazide—Dermatitis—Fluorouracil—urinary bladder cancer	0.0011	0.00469	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—GSTO2—urinary bladder cancer	0.00109	0.00312	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NAT1—urinary bladder cancer	0.00109	0.00312	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—UGT2B7—urinary bladder cancer	0.00109	0.00311	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Etoposide—urinary bladder cancer	0.00109	0.00464	CcSEcCtD
Bendroflumethiazide—Nausea—Gemcitabine—urinary bladder cancer	0.00105	0.0045	CcSEcCtD
Bendroflumethiazide—Vomiting—Cisplatin—urinary bladder cancer	0.00105	0.00449	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—UGT2B7—urinary bladder cancer	0.00104	0.00298	CbGpPWpGaD
Bendroflumethiazide—Rash—Cisplatin—urinary bladder cancer	0.00104	0.00445	CcSEcCtD
Bendroflumethiazide—Dermatitis—Cisplatin—urinary bladder cancer	0.00104	0.00445	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Etoposide—urinary bladder cancer	0.00104	0.00443	CcSEcCtD
Bendroflumethiazide—Nausea—Fluorouracil—urinary bladder cancer	0.00104	0.00443	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNA2—urinary bladder cancer	0.00103	0.00293	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UGT2B7—urinary bladder cancer	0.001	0.00286	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Etoposide—urinary bladder cancer	0.001	0.00428	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Epirubicin—urinary bladder cancer	0.000999	0.00427	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—TYMP—urinary bladder cancer	0.000998	0.00285	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.000986	0.00281	CbGpPWpGaD
Bendroflumethiazide—Nausea—Cisplatin—urinary bladder cancer	0.000981	0.0042	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—CYP4B1—urinary bladder cancer	0.000981	0.0028	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Etoposide—urinary bladder cancer	0.000962	0.00411	CcSEcCtD
Bendroflumethiazide—Rash—Etoposide—urinary bladder cancer	0.000954	0.00408	CcSEcCtD
Bendroflumethiazide—Dermatitis—Etoposide—urinary bladder cancer	0.000953	0.00408	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.00094	0.00268	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000926	0.00264	CbGpPWpGaD
Bendroflumethiazide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000925	0.00395	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—PRSS3—urinary bladder cancer	0.000903	0.00258	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NAT2—urinary bladder cancer	0.000903	0.00258	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP4B1—urinary bladder cancer	0.000902	0.00257	CbGpPWpGaD
Bendroflumethiazide—Nausea—Etoposide—urinary bladder cancer	0.000899	0.00384	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000899	0.00257	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000888	0.00253	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000888	0.00379	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000865	0.00247	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Methotrexate—urinary bladder cancer	0.000864	0.00369	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—EP300—urinary bladder cancer	0.000857	0.00245	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC19A1—urinary bladder cancer	0.000851	0.00243	CbGpPWpGaD
Bendroflumethiazide—Hypotension—Methotrexate—urinary bladder cancer	0.000847	0.00362	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000831	0.00355	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—PRSS3—urinary bladder cancer	0.00083	0.00237	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Epirubicin—urinary bladder cancer	0.000809	0.00346	CcSEcCtD
Bendroflumethiazide—Hypotension—Epirubicin—urinary bladder cancer	0.000793	0.00339	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000788	0.00337	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—RRM2—urinary bladder cancer	0.000779	0.00222	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000769	0.00329	CcSEcCtD
Bendroflumethiazide—Anorexia—Doxorubicin—urinary bladder cancer	0.000748	0.0032	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000737	0.00315	CcSEcCtD
Bendroflumethiazide—Hypotension—Doxorubicin—urinary bladder cancer	0.000733	0.00314	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—PLAU—urinary bladder cancer	0.000729	0.00208	CbGpPWpGaD
Bendroflumethiazide—Constipation—Epirubicin—urinary bladder cancer	0.000725	0.0031	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—HPGDS—urinary bladder cancer	0.000722	0.00206	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ENO2—urinary bladder cancer	0.000722	0.00206	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000722	0.00206	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTT1—urinary bladder cancer	0.0007	0.002	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000692	0.00197	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000682	0.00292	CcSEcCtD
Bendroflumethiazide—Constipation—Doxorubicin—urinary bladder cancer	0.000671	0.00287	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—TYMP—urinary bladder cancer	0.000663	0.00189	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NAT2—urinary bladder cancer	0.000653	0.00186	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Methotrexate—urinary bladder cancer	0.00065	0.00278	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000626	0.00179	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Methotrexate—urinary bladder cancer	0.00062	0.00265	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—urinary bladder cancer	0.000613	0.00175	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Epirubicin—urinary bladder cancer	0.000609	0.0026	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—CREBBP—urinary bladder cancer	0.000601	0.00172	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NAT2—urinary bladder cancer	0.0006	0.00171	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Methotrexate—urinary bladder cancer	0.000599	0.00256	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF1—urinary bladder cancer	0.000594	0.00169	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NQO1—urinary bladder cancer	0.000582	0.00166	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Epirubicin—urinary bladder cancer	0.00058	0.00248	CcSEcCtD
Bendroflumethiazide—Vomiting—Methotrexate—urinary bladder cancer	0.000576	0.00246	CcSEcCtD
Bendroflumethiazide—Rash—Methotrexate—urinary bladder cancer	0.000572	0.00244	CcSEcCtD
Bendroflumethiazide—Dermatitis—Methotrexate—urinary bladder cancer	0.000571	0.00244	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—RRM2—urinary bladder cancer	0.000563	0.00161	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Doxorubicin—urinary bladder cancer	0.000563	0.00241	CcSEcCtD
Bendroflumethiazide—Dizziness—Epirubicin—urinary bladder cancer	0.000561	0.0024	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000549	0.00157	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—RHOA—urinary bladder cancer	0.000544	0.00155	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—RRM2—urinary bladder cancer	0.00054	0.00154	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Epirubicin—urinary bladder cancer	0.000539	0.00231	CcSEcCtD
Bendroflumethiazide—Nausea—Methotrexate—urinary bladder cancer	0.000538	0.0023	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000537	0.0023	CcSEcCtD
Bendroflumethiazide—Rash—Epirubicin—urinary bladder cancer	0.000535	0.00229	CcSEcCtD
Bendroflumethiazide—Dermatitis—Epirubicin—urinary bladder cancer	0.000534	0.00228	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—ENO2—urinary bladder cancer	0.000522	0.00149	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.000522	0.00149	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Doxorubicin—urinary bladder cancer	0.000519	0.00222	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—RRM2—urinary bladder cancer	0.000518	0.00148	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000506	0.00144	CbGpPWpGaD
Bendroflumethiazide—Nausea—Epirubicin—urinary bladder cancer	0.000504	0.00215	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.0005	0.00143	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ENO2—urinary bladder cancer	0.0005	0.00143	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Doxorubicin—urinary bladder cancer	0.000499	0.00213	CcSEcCtD
Bendroflumethiazide—Rash—Doxorubicin—urinary bladder cancer	0.000495	0.00212	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000494	0.00211	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000485	0.00138	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTP1—urinary bladder cancer	0.000485	0.00138	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ENO2—urinary bladder cancer	0.00048	0.00137	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HPGDS—urinary bladder cancer	0.00048	0.00137	CbGpPWpGaD
Bendroflumethiazide—Nausea—Doxorubicin—urinary bladder cancer	0.000466	0.00199	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—GSTT1—urinary bladder cancer	0.000465	0.00133	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2—urinary bladder cancer	0.000456	0.0013	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—HRAS—urinary bladder cancer	0.000451	0.00129	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TYMS—urinary bladder cancer	0.000451	0.00129	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOR1—urinary bladder cancer	0.000446	0.00127	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—urinary bladder cancer	0.000446	0.00127	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPX1—urinary bladder cancer	0.000427	0.00122	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NQO1—urinary bladder cancer	0.000421	0.0012	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ERCC2—urinary bladder cancer	0.000419	0.0012	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EP300—urinary bladder cancer	0.00041	0.00117	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NQO1—urinary bladder cancer	0.000403	0.00115	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SRC—urinary bladder cancer	0.000398	0.00114	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—urinary bladder cancer	0.000394	0.00112	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NQO1—urinary bladder cancer	0.000387	0.0011	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTP1—urinary bladder cancer	0.000351	0.001	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTP1—urinary bladder cancer	0.000336	0.00096	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—KRAS—urinary bladder cancer	0.00033	0.000941	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TYMS—urinary bladder cancer	0.000326	0.000931	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTP1—urinary bladder cancer	0.000322	0.00092	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000322	0.00092	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000322	0.00092	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARG—urinary bladder cancer	0.000319	0.000912	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TYMS—urinary bladder cancer	0.000313	0.000892	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000309	0.000882	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000309	0.000882	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX1—urinary bladder cancer	0.000309	0.000881	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CREBBP—urinary bladder cancer	0.000307	0.000876	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ERCC2—urinary bladder cancer	0.000303	0.000865	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TYMS—urinary bladder cancer	0.0003	0.000855	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOR1—urinary bladder cancer	0.000296	0.000845	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—urinary bladder cancer	0.000296	0.000845	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX1—urinary bladder cancer	0.000296	0.000845	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TP53—urinary bladder cancer	0.000293	0.000836	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000291	0.000829	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000285	0.000813	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX1—urinary bladder cancer	0.000284	0.00081	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HRAS—urinary bladder cancer	0.00028	0.0008	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ERCC2—urinary bladder cancer	0.000279	0.000795	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—urinary bladder cancer	0.000273	0.000779	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—urinary bladder cancer	0.000262	0.000747	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS2—urinary bladder cancer	0.000251	0.000717	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARG—urinary bladder cancer	0.000231	0.000659	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CREBBP—urinary bladder cancer	0.000222	0.000633	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARG—urinary bladder cancer	0.000221	0.000632	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTEN—urinary bladder cancer	0.000219	0.000626	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CREBBP—urinary bladder cancer	0.000213	0.000607	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARG—urinary bladder cancer	0.000212	0.000606	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—EP300—urinary bladder cancer	0.000209	0.000597	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CREBBP—urinary bladder cancer	0.000204	0.000582	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS2—urinary bladder cancer	0.000182	0.000519	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS2—urinary bladder cancer	0.000174	0.000497	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS2—urinary bladder cancer	0.000167	0.000477	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTEN—urinary bladder cancer	0.000158	0.000452	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTEN—urinary bladder cancer	0.000152	0.000434	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—EP300—urinary bladder cancer	0.000151	0.000431	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTEN—urinary bladder cancer	0.000146	0.000416	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—EP300—urinary bladder cancer	0.000145	0.000413	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—EP300—urinary bladder cancer	0.000139	0.000396	CbGpPWpGaD
